Orasis is an emerging ophthalmic pharmaceutical company with the goal of making near vision clear again. They are committed to the Ophthalmology and Optometry segments because they know that presbyopia is ubiquitous. By virtue of their first in class formulation, Orasis is well-positioned to be first-line therapy in this emerging category by addressing a significant unmet need for patients.

Pharmaceutical

Orasis Pharmaceuticals

Elad Kedar

Yaron Shimon

Merav Zeide

Ilan Rubin

Paul Smith

Iris Meisner

Ron Neumann

Sharon Amzel-Sasson

The Clinical and Medical Affairs team at Orasis Pharmaceuticals oversees the clinical development and medical strategy for the company's ophthalmic treatments. They manage clinical trials, ensure regulatory compliance, and liaise with the medical community to support the efficacy and safety of Orasis's pioneering therapies for presbyopia.

Clinical and Medical Affairs

Advisory and Board Team

Leadership Team

Clinical and Medical Affairs

About

Team members

Other teams at Orasis Pharmaceuticals

Advisory and Board Team

Leadership Team